Medvi GLP-1 Review (2026): Pros, Cons & Honest Verdict

Quick answer: Medvi is an online telehealth program offering compounded semaglutide ($179+ first month, $299/mo ongoing), compounded tirzepatide ($279+ first month, $399/mo ongoing), and branded GLP-1 options. Includes unlimited messaging and visits with licensed providers, free shipping, and prepay discounts.

How Medvi works

Medvi's enrollment flow follows the standard telehealth GLP-1 playbook with a few brand-specific characteristics:

1. Take the eligibility quiz — a short online intake covering health goals, medical history, current medications, allergies, and basic biometrics.
2. Provider review — an independent licensed provider reviews your submission. If you're clinically appropriate, they issue a prescription with a specific medication and dose. Medvi emphasizes the "doctor-guided" nature of this step in its marketing.
3. Medication ships free — once approved, your medication is dispatched directly to your door at no additional shipping cost. Tracking is provided.
4. Ongoing care included — unlimited messaging with the care team and unlimited telehealth visits are bundled into the monthly cost. This is a meaningful differentiator versus providers that charge per visit or limit support hours.

Medvi pricing in 2026 (full breakdown)

Pricing is where Medvi is most complex — and most worth understanding before signing up. The first-month promotional rate is significantly cheaper than the ongoing rate, so the "starting at" headlines can mislead if you're budgeting for a 6-12 month course of treatment.

What's included at every tier: medication, all consultations, unlimited provider messaging, free tracked shipping. No separate membership fee. No insurance billing (Medvi is a cash-pay model — confirm current accepted payments on their site).

The most useful pricing lever Medvi offers: prepay discounts on 3-, 6-, and 12-month plans. If you're committed to a longer course, prepaying can meaningfully reduce your effective monthly cost. Confirm current discount tiers on Medvi's site before purchase.

Medications Medvi offers

Medvi's lineup is one of the broadest in the U.S. telehealth GLP-1 category:

• Compounded semaglutide — injectable and oral tablet forms. Same active ingredient as branded Ozempic and Wegovy.
• Compounded tirzepatide — injectable and tablet forms. Same active ingredient as branded Zepbound and Mounjaro.
• Branded GLP-1 options — Ozempic and Wegovy available at cash-pay retail-equivalent pricing. Useful if a clinician determines a branded product is the right fit for your case.
• Adjacent categories — peptides & longevity, men's health (sexual wellness), and women's health products are available through the same Medvi account.

The oral GLP-1 option — what to know

Medvi is one of the few providers offering oral tablet formulations of both semaglutide and tirzepatide. Oral GLP-1 is an option for patients who are needle-averse or have other reasons to avoid subcutaneous injections. Bioavailability of oral GLP-1 differs from injectable, which is partly why the prescribed dose schedules differ. Discuss the injection-versus-oral choice with the prescribing clinician.

Are Medvi medications compounded or FDA-approved?

This distinction is the single most-misunderstood part of every compounded-GLP-1 review online — and the one most worth getting right before signing up. We'll be direct.

Medvi's $299 semaglutide and $399 tirzepatide are compounded GLP-1 medications — prepared by Medvi's pharmacy partner Belmar Pharma Solutions (operating since 1985, NABP-accredited at all six locations, licensed in all 50 states, LegitScript certified, sourcing ingredients from FDA-registered facilities), prescribed by U.S.-licensed clinicians through the OpenLoop Health physician network, using the same active pharmaceutical ingredients (semaglutide or tirzepatide) as branded products. Compounded medications are not FDA-approved as finished drug products — they have not gone through the FDA review process for finished-product safety, efficacy, and quality that branded Wegovy, Ozempic, Zepbound, and Mounjaro completed. This caveat is not unique to Medvi — it applies to every compounded GLP-1 provider on the U.S. market in 2026, including Oak, TrimRx, DirectMeds, Gala, System, and FeelGood. Medvi's branded Ozempic ($750-$950/mo) and Wegovy ($950-$1,150/mo) are the FDA-approved options on the platform.

Side effects & safety

Medvi's GLP-1 medications carry the same side-effect profile as any other GLP-1 provider's lineup, because the active ingredients are identical. Common effects include nausea, vomiting, diarrhea, constipation, abdominal pain, fatigue, and reduced appetite — typically dose-dependent and most pronounced during the early titration weeks. For a full breakdown, see our GLP-1 side effects guide.

GLP-1 medications carry a boxed warning for thyroid C-cell tumors based on animal studies. Patients with personal or family history of medullary thyroid carcinoma or MEN2 syndrome should not use them. Pregnancy is a contraindication.

Who Medvi is best for

Medvi is a strong fit if you:

• Want extensive provider access — unlimited messaging and visits are genuinely useful for managing titration questions
• Want both compounded and branded GLP-1 on the same platform (rare in the category)
• Prefer the option of oral tablets over injections
• Are willing to prepay 3-12 months for a better effective monthly rate
• Need adjacent products (men's/women's health, peptides) from the same provider

Medvi is not the best fit if you:

• Are looking for the absolute lowest published price (Oak is cheaper at $133/mo for compounded semaglutide)
• Prefer no-subscription, pay-per-shipment models
• Don't need extensive provider messaging
• Are pregnant, nursing, under 18, or have contraindications listed above

Real Medvi patient feedback

Aggregating public reviews across third-party platforms, Medvi patient sentiment clusters around two consistent themes:

• Positive: Provider responsiveness via messaging, the breadth of medication options, and the convenience of unlimited visits being included in monthly pricing.
• Critical: The ongoing monthly rate jump after the first promotional month surprises some patients who didn't read the fine print. Occasional reports of slow refill turnaround during peak periods.

The doctor-guided positioning isn't just marketing — Medvi's unlimited messaging model genuinely changes how patients experience titration versus async-only competitors.— Bartley Editorial Analysis

Medvi vs alternatives

If your priority is the lowest published price and you don't need extensive provider messaging, Oak's compounded semaglutide at $133/mo is hard to beat. If you specifically want broader medication options (oral GLP-1, branded availability) and bundled unlimited provider access, Medvi's premium pricing buys real value.

Medvi pros and cons

Medvi sign-up & ongoing-care checklists

If you decide Medvi is the right fit, the three checklists below cover the practical details most buyers wish they'd known before signing up. Bookmark this section — most issues we see surface in any compounded-GLP-1 program come from skipping one of these items, not from the medication itself. Every item below is drawn directly from real Medvi patient reviews and BBB complaint patterns we analyzed.

Medvi frequently asked questions

How much does Medvi GLP-1 cost in 2026?

Medvi's compounded semaglutide injections start at $179 for the first month and $299 ongoing. Compounded tirzepatide (injection or oral) starts at $279 first month and $399 ongoing. Branded Ozempic costs $750 first month / $950 ongoing; branded Wegovy is $950 first / $1,150 ongoing.

Is Medvi GLP-1 legit?

Yes. Medvi is a U.S. telehealth platform that connects patients with independent licensed providers. Prescriptions are issued only after an online consultation. Compounded medications are dispensed by state-licensed pharmacies, though they are not FDA-approved as finished products.

Does Medvi accept insurance?

Medvi operates primarily as a cash-pay telehealth platform. Some categories may interact with insurance per their site disclosure, but GLP-1 medications are cash-pay in most cases. Confirm current insurance handling on Medvi's official site.

Does Medvi offer oral GLP-1 medications?

Yes. Medvi is one of the few telehealth providers offering both injectable and oral tablet forms of compounded semaglutide and tirzepatide. Oral options carry different pricing than injections.

What's included in Medvi's monthly cost?

Each monthly cost includes the medication, unlimited messaging with your provider, unlimited telehealth visits as needed, free tracked shipping, and any care-team support during titration. There is no separate membership fee.

Can I save money by prepaying with Medvi?

Yes. Medvi offers discounts when you prepay for 3, 6, or 12 months. The effective monthly rate can be meaningfully lower than month-to-month pricing. Always confirm current discount tiers on Medvi's official site.

What are Medvi GLP-1 side effects?

Side effects are the same as any GLP-1 medication: nausea, vomiting, diarrhea, constipation, fatigue, and reduced appetite are most common, typically dose-dependent. Discuss with your prescribing provider.

How is Medvi different from Oak GLP-1?

Oak is meaningfully cheaper ($133/mo compounded semaglutide vs Medvi's $299) and uses a no-subscription model. Medvi is more expensive but includes unlimited provider messaging and visits, broader medication options (oral GLP-1 + branded), and prepay discounts. The right choice depends on whether you prioritize price or provider access.

Is Medvi the same as MEDvidi?

No — these are two completely unrelated companies often confused because of similar names. Medvi (medvi.org) is a weight-loss and GLP-1 telehealth platform headquartered in Newark, Delaware. MEDvidi (medvidi.com) is a separate mental-health telehealth company based in San Jose, California. They are not affiliated. The BBB complaint and review confusion you may see when researching Medvi is partly the result of this name collision; MEDvidi has publicly asked reviewers to verify which company they are actually reviewing.

Are Medvi medications compounded or FDA-approved?

Medvi primarily prescribes compounded GLP-1 medications, which are produced by U.S.-licensed compounding pharmacies (Medvi's partner is Belmar Pharma Solutions, in operation since 1985, NABP-accredited at all six locations, licensed in all 50 states, and LegitScript certified). Compounded medications use licensed active ingredients but are not FDA-approved as finished drug products. Medvi also offers FDA-approved branded options (Ozempic $750-$950/mo, Wegovy $950-$1,150/mo) for patients who want the brand-name path. The compounded vs FDA-approved distinction applies to every compounded GLP-1 provider, not just Medvi. See our compounded vs FDA-approved deep-dive above.

How do I cancel Medvi?

Medvi's billing cycle is every 28 days, which works out to 13 charges per year (not 12). To cancel, give at least 72 hours notice before your next billing date — though we recommend a 5-day buffer. Use the Medvi portal AND send a confirmation email for documentation, screenshot the confirmation, and watch your card statement for 30 days. You can cancel anytime; there is no long-term contract. See our full cancellation checklist above for step-by-step.

Is Medvi available in my state?

Medvi is available in 49 U.S. states — every state except North Dakota. Six states (Kansas, Indiana, Mississippi, New Mexico, Oklahoma, and West Virginia) require a video consultation rather than an asynchronous intake per their state telehealth laws. The Medvi eligibility quiz will flag any state-specific requirement at intake.

Are compounded GLP-1 medications still legal in 2026?

Yes. The FDA resolved the official semaglutide shortage in early 2025, which changed the rules around which pharmacies can compound at scale. However, 503A pharmacies — like Medvi's partner Belmar Pharma Solutions — can still legally compound patient-specific prescriptions when a licensed clinician determines a medical need exists. Litigation from the Outsourcing Facilities Association is ongoing. Compounded GLP-1 medications remain available through licensed telehealth platforms including Medvi in 2026, though the long-term pricing landscape may shift in 2027-2028 as supply consolidates.

Honest verdict — should you choose Medvi GLP-1?

Medvi is a strong choice for a specific kind of patient — and the wrong choice for another. After working through Medvi's pricing structure, medication lineup, signup flow, and where it sits in the broader 2026 U.S. telehealth GLP-1 market, the honest answer is that Medvi earns its 4.3/5 editor's rating on the strength of three things: genuinely accessible doctor-guided care (the unlimited provider messaging and visits are not just marketing — they meaningfully change the patient experience versus async-only competitors), one of the broadest medication menus in the category (compounded injection + compounded oral + branded options on the same platform is rare), and pricing transparency for what's actually included in the monthly cost.

What pulls the rating down from a higher mark is straightforward: the ongoing monthly rate after the first promotional month — $299 for compounded semaglutide and $399 for compounded tirzepatide — is meaningfully more expensive than the category's price leaders. If your decision is being driven primarily by month-to-month cost, Oak's $133/mo semaglutide and $199/mo tirzepatide are difficult to argue against and we recommend reading our independent Oak review alongside this one to compare apples-to-apples.

Expert advice: who should sign up for Medvi today

Sign up for Medvi if any of the following apply to you:

• You want a real human clinician you can message anytime. Unlimited messaging and telehealth visits are bundled into every Medvi plan. For first-time GLP-1 patients navigating titration questions, side-effect management, and dose changes, this is genuinely valuable — and most competitors charge extra (or don't offer it at all).
• You want oral GLP-1 as an option. Medvi is one of only a small number of telehealth providers offering oral tablet formulations of semaglutide and tirzepatide. If you're needle-averse or curious about non-injectable routes, this is one of your best legitimate options.
• You want access to branded medications on the same platform. Most compounded-focused providers don't offer Ozempic or Wegovy at all. Medvi does, at cash-pay retail-equivalent pricing — useful if your prescribing clinician determines a branded product is the right fit.
• You can prepay 3, 6, or 12 months. The prepay discount tiers materially reduce your effective monthly cost. If you're committed to a long course of treatment, the prepay route is the smart way to use Medvi.
• You want a single provider for adjacent goals. Medvi's peptides/longevity, men's health, and women's health verticals run through the same account — convenient if you're managing multiple wellness goals.

The bottom line

If you're someone who values extensive provider access, wants medication flexibility (oral, injection, compounded, branded), and is willing to pay a premium for those features, Medvi is one of the cleanest executions of that model in the U.S. market in 2026. Take the eligibility quiz, see if you qualify, and lock in the promotional first-month rate. The unlimited messaging and visits, broad medication menu, and prepay-discount structure combine to make Medvi a credible top-tier choice for the right patient profile.

Published: May 27, 2026 · Last updated: June 3, 2026 · Pricing & certifications verified: June 2026 · Spot a factual issue? Tell our editors.